Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VIDEO: FSD Pharma CEO Raza Bokhari updates investors on ‘HUGE’ news

Stockhouse Media, Stockhouse.com
5 Comments| October 24, 2019

{{labelSign}}  Favorites
{{errorMessage}}

FSD Pharma Inc.(CSE: HUGE, OTCQB: FSDDF, Forum) is focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders including chronic pain, fibromyalgia and irritable bowel syndrome, and on the development of the highest quality indoor grown, pharmaceutical-grade cannabis.

'HUGE' is a publicly-traded company and through its wholly-owned subsidiary holds an 'Access to Cannabis for Medical Purposes Regulation' license to cultivate cannabis. It is engaged in the production and sale of medical cannabis.

All of the company's operations are situated in Canada.



(Click here to play video)

FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company